Crossref
Serum FcεRI as a Putative Biomarker of Disease Severity and Immune Perturbation in Paediatric and Adult Atopic Dermatitis
Asthma Allergy Immunology · 23.12.2025 · 23 (3) · 251-262
DOI: 10.21911/aai.2025.863 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asthma Allergy Immunology, online erschienen am 23.12.2025. Verfasst von Bandar Ibrahim AAYF AL-SHAMMARI und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
AL-SHAMMARI, B. I. A., & AL-ALLAFF, R. G. M. (2025). Serum FcεRI as a Putative Biomarker of Disease Severity and Immune Perturbation in Paediatric and Adult Atopic Dermatitis. Asthma Allergy Immunology, 23(3), 251-262. https://doi.org/10.21911/aai.2025.863
Vancouver
AL-SHAMMARI BIA, AL-ALLAFF RGM. Serum FcεRI as a Putative Biomarker of Disease Severity and Immune Perturbation in Paediatric and Adult Atopic Dermatitis. Asthma Allergy Immunology. 2025;23(3):251-262. doi:10.21911/aai.2025.863
BibTeX
@article{ALSHAMMARI2025,
author = {AL-SHAMMARI, Bandar Ibrahim AAYF and AL-ALLAFF, Rojan Ghanim MOHAMMED},
title = {Serum FcεRI as a Putative Biomarker of Disease Severity and Immune Perturbation in Paediatric and Adult Atopic Dermatitis},
journal = {Asthma Allergy Immunology},
year = {2025},
volume = {23},
number = {3},
pages = {251--262},
doi = {10.21911/aai.2025.863}
}
EUVIMED